Through the Global Gateway strategy, the European Union mobilised more than EUR 2 billion for regional manufacturing of vaccines and medicines.

Omissions

• The figure refers to contributions from the EU institutions AND the EU Member States combined (Team Europe), not from the EU budget alone; the claim's 'we mobilised' should be understood as Team Europe.
• The bulk of this funding is channelled through the MAV+ Team Europe Initiative, which is largely focused on Africa, so the geographic scope is global but with an African emphasis.
• Exact publication date of the EEAS page could not be confirmed from the search results; the underlying figure is consistent across official EU and independent academic sources.

Sources

• PrimaryEuropean External Action Service (EEAS) — EU Delegation to the African UnionThrough Global Gateway, the EU and its Member States have also mobilised more than €2 billion for the regional manufacture of vaccines, medicines and health products.
• AcademicCEPS — Health under the Global Gateway: achievements and futureMAV+ is a TEI of almost EUR 2 billion in ...
• AcademicEUIdeas (European University Institute) — Beyond the EU Global GatewayThe MAV+ is a major €2 billion Team Europe flagship project under the EU's Global Gateway strategy to help African countries strengthen local ...